C2C Wealth Management’s AbbVie ABBV Stock Holding History

C2C Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.02M	Buy	4,056 +2	+0%	+$430	0.8%	31
2026 Q1	$882K	Buy	4,054 +2	+0%	+$444	0.75%	33
2025 Q4	$926K	Hold	4,052	–	–	0.78%	31
2025 Q3	$938K	Hold	4,052	–	–	0.81%	31
2025 Q2	$752K	Buy	4,052 +42	+1%	+$7.81K	0.68%	35
2025 Q1	$840K	Hold	4,010	–	–	0.79%	33
2024 Q4	$713K	Buy	4,010 +63	+2%	+$11.6K	0.66%	36
2024 Q3	$805K	Hold	3,947	–	–	0.75%	34
2024 Q2	$677K	Hold	3,947	–	–	0.66%	35
2024 Q1	$719K	Sell	3,947 -5,079	-56%	-$875K	0.71%	34
2023 Q4	$1.26M	Sell	9,026 -20,328	-69%	-$2.96M	1.07%	24
2023 Q3	$4.33M	Buy	29,354 +3	+0%	+$440	0.62%	12
2023 Q2	$3.96M	Buy	29,351 +503	+2%	+$73.8K	0.52%	16
2023 Q1	$4.68M	Buy	28,848 +3,521	+14%	+$538K	0.76%	12
2022 Q4	$3.8M	Sell	25,327 -2,424	-9%	-$372K	0.66%	14
2022 Q3	$3.94M	Sell	27,751 -307	-1%	-$44.1K	0.77%	12
2022 Q2	$4.2M	Sell	28,058 -298	-1%	-$45.5K	0.77%	13
2022 Q1	$4.45M	Sell	28,356 -7,498	-21%	-$1.09M	0.76%	13
2021 Q4	$4.86M	Buy	+35,854	New	+$4.24M	0.7%	13

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

C2C Wealth Management's ABBV Position: Q2 2026 in Review

C2C Wealth Management increased its AbbVie (ABBV) stake by 0.05% in Q2 2026, buying an estimated $430 and bringing the position to 4,056 shares worth $1.02M. The position accounts for 0.8% of the portfolio, ranked #31.

C2C Wealth Management first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $4.86M in Q4 2021. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

C2C Wealth Management held 4,056 shares of AbbVie worth $1.02M as of Q2 2026.
C2C Wealth Management bought 2 AbbVie shares in Q2 2026, an estimated $430.
AbbVie made up 0.8% of C2C Wealth Management's portfolio in Q2 2026, its #31 holding.
C2C Wealth Management first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
C2C Wealth Management's AbbVie position peaked at $4.86M in Q4 2021.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on C2C Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.